398137-18-3

Upstream product

• 16588-02-6 4-chloro-3-cyanonitrobenzene 
• 16588-15-1 2-chloro-5-nitro-benzamide 
• 111-42-2 2,2'-iminobis[ethanol] 
• 156079-58-2 2-bis(2-hyroxyethyl)amino-5-nitrobenzonitrile 

Downstream Products

• 288250-04-4 N-{3-cyano-4-[bis(2-hydroxyethyl)amino]phenyl}-1-(4-fluorophenyl)-5-methylpyrazole-4-carboxamide 
• 398136-99-7 [3-(N-(4-[N,N-bis(2-hydroxyethyl)amino]-3-cyanophenyl)carbamoyl)-5-fluoro-2-methylindol-1-yl]acetic Acid 
• 398137-00-3 N-[4-(N,N-bis(2-hydroxyethyl)amino)-3-cyanophenyl]benzo[b]thiophene-2-carboxamide 

Relevant academic research and scientific papers

Fused bicyclic amide compounds and medicinal use thereof

The present invention provides a compound represented by the formula (I) wherein ring A is benzene, cyclohexane, pyridine, piperidine or a derivative thereof, imidazole or a derivative thereof and the like, ring B is benzene, cyclohexane, pyrrole or a derivative thereof, furan, thiophene and the like, R1, R2 and R3 are each hydrogen, alkyl, halogen, hydroxyl group, alkoxy and the like, W is hydrogen, alkyl or hydroxycarbonylalkyl, X is halogen, cyano, nitro and the like, X′ is hydrogen, halogen and the like, and Y is alkyl, hydroxyalkyl, hydroxycarbonylalkyl, aminoalkyl and the like, a salt thereof, and a pharmaceutical agent containing the compound. The compound of the present invention shows a superior inhibitory effect on the proliferation of activated lymphocyte and is useful as an agent for the prophylaxis or treatment of various autoimmune diseases.

AMIDE COMPOUNDS AND MEDICINAL USE THEREOF

The present invention relates to a compound of the formula wherein R1 is substituted aryl, heteroaryl and the like, R2 and R3 are hydrogen, alkyl, halogen, hydroxyl group and the like, Q is N, CH and the like, W is hydrogen, alkyl, hydroxycarbonylalkyl and the like, X is halogen, cyano, nitro, amino and the like, X' is hydrogen, halogen, cyano, nitro, and Y is alkyl, hydroxyl group, alkoxy, mercapto and the like and a salt thereof, and a medicine containing the said compound. The compound of the present invention shows a superior inhibitory effect on activated lymphocytes proliferation and is useful as an agent for the prophylaxis or treatment of various autoimmune diseases.